BBA
Baker Bros. Advisors’s Edgewise Therapeutics EWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.8M | Buy |
7,305,940
+1,150,000
| +19% | +$15.1M | 0.93% | 13 |
|
|
2025
Q1 | $135M | Hold |
6,155,940
| – | – | 1.5% | 11 |
|
|
2024
Q4 | $164M | Buy |
6,155,940
+315,881
| +5% | +$8.43M | 1.76% | 11 |
|
|
2024
Q3 | $156M | Hold |
5,840,059
| – | – | 1.62% | 11 |
|
|
2024
Q2 | $105M | Hold |
5,840,059
| – | – | 1.34% | 11 |
|
|
2024
Q1 | $107M | Buy |
5,840,059
+2,727,273
| +88% | +$49.7M | 1.34% | 10 |
|
|
2023
Q4 | $34.1M | Buy |
3,112,786
+2,063,087
| +197% | +$22.6M | 0.39% | 30 |
|
|
2023
Q3 | $6.01M | Buy |
1,049,699
+549,699
| +110% | +$3.15M | 0.03% | 63 |
|
|
2023
Q2 | $3.88M | Hold |
500,000
| – | – | 0.02% | 78 |
|
|
2023
Q1 | $3.34M | Hold |
500,000
| – | – | 0.02% | 81 |
|
|
2022
Q4 | $4.47M | Hold |
500,000
| – | – | 0.03% | 79 |
|
|
2022
Q3 | $4.92M | Hold |
500,000
| – | – | 0.03% | 81 |
|
|
2022
Q2 | $3.98M | Hold |
500,000
| – | – | 0.02% | 83 |
|
|
2022
Q1 | $4.85M | Hold |
500,000
| – | – | 0.03% | 85 |
|
|
2021
Q4 | $7.64M | Hold |
500,000
| – | – | 0.04% | 83 |
|
|
2021
Q3 | $8.3M | Hold |
500,000
| – | – | 0.04% | 81 |
|
|
2021
Q2 | $10.7M | Hold |
500,000
| – | – | 0.05% | 75 |
|
|
2021
Q1 | $16.3M | Buy |
+500,000
| New | +$16.3M | 0.07% | 63 |
|